Mental health disorders like PTSD and depression might not be as much of a barrier to cardiac rehabilitation as was previously thought, according to a study of more than 85,000 U.S. veterans published in the Journal of the American Heart Association.
Corindus Vascular Robotics’ CorPath GRX system—the world’s only FDA-approved and CE-marked robotic platform for percutaneous coronary intervention (PCI) and peripheral vascular intervention—was used to successfully perform a remote PCI from more than 350 miles away during this year’s EuroPCR congress.
Women are less likely to be resuscitated by bystanders than men in cases of out-of-hospital cardiac arrest, and when resuscitation is attempted they see lower survival rates, according to research published in the European Heart Journal May 21.
Bypassing standard angiography and skipping straight to an MRI might help physicians more easily identify and treat patients who have suffered non-ST segment elevation myocardial infarction (NSTEMI), a team at Weill Cornell Medicine and NewYork-Presbyterian have found.
More than two-thirds of CV randomized clinical trial reports positively spin some aspect of the article to reflect favorable results that aren’t necessarily there, according to a study published in the May edition of JAMA Network Open.
Three-year results of the BIO-RESORT study, presented at EuroPCR this week in Paris, put Biotronik’s ultrathin Orsiro stent ahead of two other competitors in terms of target lesion failure and revascularization.
An absorbable, antibiotic-eluting mesh envelope significantly reduced the incidence of major cardiac implantable electronic device (CIED) infections in a recent study of nearly 7,000 patients, researchers reported in the New England Journal of Medicine May 16.